We are live on ! Find out more
PHGE icon

BiomX
PHGE

9 hedge funds and large institutions have $2.77M invested in BiomX in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $1.93M → $2.77M (+$843K)

0.01% less ownership

Funds ownership: 0.1% → 0.09% (-0.01%)

25% less funds holding

Funds holding: 12 → 9 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
9
Holders Change
-3
Holders Change %
-25%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$425K
2
Renaissance Technologies
Renaissance Technologies
New York
+$35.8K
3
VF
Virtu Financial
New York
+$16.5K
4
MI
MMCAP International
Cayman Islands
+$11.1K
5
Millennium Management
Millennium Management
New York
+$3.83K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$59.7K
2
Citadel Advisors
Citadel Advisors
Florida
-$9.29K
3
BlackRock
BlackRock
New York
-$1.75K
4
UBS Group
UBS Group
Switzerland
-$916

PHGE Hedge Fund Activity: Q2 2023 in Review

9 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2023, worth a combined $2.77M — up 44% from $1.93M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PHGE and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was OrbiMed, adding an estimated $425K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $59.7K sold.

  • 9 institutional investors held BiomX (PHGE) as of Q2 2023, down from 12 in Q1 2023.
  • Funds reported $2.77M of BiomX stock for Q2 2023, up 44% quarter-over-quarter.
  • 1 fund opened new BiomX positions in Q2 2023 and 4 closed out, a net change of -3 holders.
  • The largest BiomX buyer in Q2 2023 was OrbiMed, an estimated $425K added.
  • The largest BiomX seller in Q2 2023 was Susquehanna International Group, an estimated $59.7K sold.

Based on aggregated 13F filings for Q2 2023.